FI77877C
(fi)
*
|
1979-04-20 |
1989-05-10 |
Technobiotic Ltd |
Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
|
US4460685A
(en)
*
|
1980-05-29 |
1984-07-17 |
New York University |
Method of enhancing the production of human γ Interferon
|
DE3280127D1
(de)
*
|
1981-03-27 |
1990-04-12 |
Ici Plc |
Genetisch modifizierte mikroorganismen.
|
JPS58146281A
(ja)
*
|
1981-10-19 |
1983-08-31 |
Suntory Ltd |
酵母細胞の形質転換法
|
US4775622A
(en)
*
|
1982-03-08 |
1988-10-04 |
Genentech, Inc. |
Expression, processing and secretion of heterologous protein by yeast
|
JP2608540B2
(ja)
*
|
1982-05-19 |
1997-05-07 |
ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ |
クルイベロミセス種のためのクローニング系
|
GB2125047B
(en)
*
|
1982-08-09 |
1986-02-19 |
Ciba Geigy Ag |
Yeast hybrid vectors and their use for the production of polypeptides
|
IL69202A
(en)
*
|
1982-09-08 |
1991-08-16 |
Smith Kline Rit |
Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
|
JPH0716432B2
(ja)
*
|
1982-10-20 |
1995-03-01 |
サントリー株式会社 |
酵母の高発現ベクタープラスミドを用いたペプチドの生産方法
|
DE3382547D1
(de)
*
|
1983-01-12 |
1992-05-27 |
Chiron Corp |
Sekretorische expression in eukaryoten.
|
IE56720B1
(en)
*
|
1983-02-07 |
1991-11-20 |
Battelle Memorial Institute |
Methods and compositions for expression of competent eukaryotic gene products
|
US4876197A
(en)
*
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
CA1341116C
(en)
*
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
US4661454A
(en)
*
|
1983-02-28 |
1987-04-28 |
Collaborative Research, Inc. |
GAL1 yeast promoter linked to non galactokinase gene
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
WO1984004330A1
(en)
*
|
1983-04-22 |
1984-11-08 |
Amgen |
Secretion of exogenous polypeptides from yeast
|
US7198919B1
(en)
|
1983-04-25 |
2007-04-03 |
Genentech, Inc. |
Use of alpha factor sequences in yeast expression systems
|
ZA843275B
(en)
*
|
1983-05-05 |
1984-12-24 |
Hoffmann La Roche |
Novel vectors for interferon expression
|
EP0143821A1
(de)
*
|
1983-05-19 |
1985-06-12 |
Transgene S.A. |
Verfahren zur herstellung von catechol 2,3-oxygenase durch hefe, plasmid für dessen herstellung und verwendung
|
EP0129268B1
(de)
*
|
1983-05-19 |
1989-10-04 |
Unilever N.V. |
Verbesserungen in der Expression von neu eingeführten Genen in Hefezellen
|
US4870008A
(en)
*
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
WO1985001516A1
(fr)
*
|
1983-10-03 |
1985-04-11 |
Transgene S.A. |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
FR2552776B1
(fr)
*
|
1983-10-03 |
1986-05-09 |
Transgene Sa |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
FR2562090B2
(fr)
*
|
1984-03-27 |
1988-04-08 |
Transgene Sa |
Proteine antigenique de la rage glycosylee
|
US5639639A
(en)
*
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
PH23920A
(en)
*
|
1983-12-20 |
1990-01-23 |
Cetus Corp |
Glucoamylase cdna
|
GB8334261D0
(en)
*
|
1983-12-22 |
1984-02-01 |
Bass Plc |
Fermentation processes
|
EP0154576A1
(de)
*
|
1984-02-06 |
1985-09-11 |
INTERFERON SCIENCES, INC a Delaware Corporation |
Hybrid-Nucleinsäuresequenzen mit tandemartig angeordneten Genen
|
US4626505A
(en)
*
|
1984-02-24 |
1986-12-02 |
E. I. Du Pont De Nemours And Company |
Selectable markers for yeast transformation
|
US4745057A
(en)
*
|
1984-05-18 |
1988-05-17 |
Eli Lilly And Company |
Method, vectors and transformants for high expression of heterologous polypeptides in yeast
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
US5683688A
(en)
*
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
SE8403929L
(sv)
*
|
1984-07-31 |
1986-02-21 |
Sten Gatenbeck |
Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
|
US4752473A
(en)
*
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
US7273695B1
(en)
|
1984-10-31 |
2007-09-25 |
Novartis Vaccines And Diagnostics, Inc. |
HIV immunoassays using synthetic envelope polypeptides
|
US7285271B1
(en)
|
1984-10-31 |
2007-10-23 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenic composition comprising an HIV gag or env polypeptide
|
US4812405A
(en)
*
|
1986-02-18 |
1989-03-14 |
Phillips Petroleum Company |
Double auxotrophic mutants of Pichia pastoris and methods for preparation
|
JPS6447380A
(en)
*
|
1987-08-19 |
1989-02-21 |
Agency Ind Science Techn |
Steroid-oxidizing yeast strain
|
US7442525B1
(en)
|
1987-12-24 |
2008-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Method for expressing HIV polypeptides
|
US5580734A
(en)
*
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
JP4236698B2
(ja)
|
1990-11-26 |
2009-03-11 |
ジェネティックス インスティチュート,リミテッド ライアビリティ カンパニー |
宿主細胞でのpaceの発現およびその使用法
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
ATE171728T1
(de)
*
|
1994-07-29 |
1998-10-15 |
Teijin Ltd |
Trypsintyp-enzyme, dafür kodierende nukleinsäuresequenz und verfahren zur herstellung des enzymes
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
AU4977697A
(en)
|
1996-09-25 |
1998-04-17 |
Vanderbilt University |
Genetically engineered yeast with modified signal peptidase complex
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
WO1999040434A1
(en)
|
1998-02-04 |
1999-08-12 |
Invitrogen Corporation |
Microarrays and uses therefor
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP2261347A3
(de)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Antigene und Zusammensetzungen gegen Neisseria meningitidis
|
US7081360B2
(en)
*
|
1998-07-28 |
2006-07-25 |
Cadus Technologies, Inc. |
Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
CN100392082C
(zh)
|
1999-04-30 |
2008-06-04 |
启龙股份公司 |
保守的奈瑟球菌抗原
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
ES2541830T3
(es)
|
1999-10-29 |
2015-07-27 |
Novartis Vaccines And Diagnositics S.R.L. |
Péptidos antigénicos de Neisseria
|
US6232074B1
(en)
|
1999-12-10 |
2001-05-15 |
Complegen, Inc. |
Functional gene array in yeast
|
PT1248647E
(pt)
|
2000-01-17 |
2010-11-18 |
Novartis Vaccines & Diagnostics Srl |
Vacina de vesícula da membrana externa (omv) compreendendo proteínas de membrana externa de n. meningitidis do serogrupo b
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
US7780967B2
(en)
*
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
BR0108173A
(pt)
*
|
2000-02-08 |
2003-01-21 |
Allergan Inc |
Composições farmacêuticas de toxina de botulina
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
CA2747325A1
(en)
*
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US8399383B2
(en)
|
2000-05-04 |
2013-03-19 |
Yale University |
Protein chips for high throughput screening of protein activity
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
EP2322644A1
(de)
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US6737262B1
(en)
*
|
2000-07-11 |
2004-05-18 |
Robert I. Bolla |
Animal feed containing polypeptides
|
JP2002057727A
(ja)
*
|
2000-08-10 |
2002-02-22 |
Hitachi Ltd |
半導体集積回路および光通信モジュール
|
EP2277895B1
(de)
|
2000-10-27 |
2013-08-14 |
Novartis Vaccines and Diagnostics S.r.l. |
Nukleinsäure und Proteine von Gruppen A und B Streptokokken
|
AU2002225681A1
(en)
*
|
2000-11-15 |
2002-05-27 |
Globe Immune, Inc. |
Yeast-dentritic cell vaccines and uses thereof
|
US6861237B2
(en)
|
2000-11-30 |
2005-03-01 |
Novo Nordisk A/S |
Production of heterologous polypeptides in yeast
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
DE10123980B4
(de)
*
|
2001-05-17 |
2008-01-10 |
Tesa Ag |
Abschlussbandage
|
US20050106162A1
(en)
|
2001-12-12 |
2005-05-19 |
Guido Grandi |
Immunisation against chlamydia trachomatis
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
EP1463752A4
(de)
*
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
WO2003099854A2
(en)
|
2002-05-24 |
2003-12-04 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
US20040018581A1
(en)
*
|
2002-07-24 |
2004-01-29 |
Pharmacia And Upjohn Company |
Method for discovering substances for inhibiting enzymes
|
ATE466875T1
(de)
|
2002-11-15 |
2010-05-15 |
Novartis Vaccines & Diagnostic |
Unerwartete oberflächenproteine in neisseria meningitidis
|
US8343502B2
(en)
*
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
KR101164509B1
(ko)
*
|
2002-12-16 |
2012-07-10 |
글로브이뮨 |
면역 요법으로서의 효모계 백신
|
US7439042B2
(en)
*
|
2002-12-16 |
2008-10-21 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
EP1433842B1
(de)
|
2002-12-18 |
2011-01-05 |
Roche Diagnostics GmbH |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
ATE494367T1
(de)
*
|
2002-12-18 |
2011-01-15 |
Hoffmann La Roche |
Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
|
DE60319333D1
(de)
*
|
2002-12-20 |
2008-04-10 |
Roche Diagnostics Gmbh |
Hitzelabile Desoxyribonuklease I-Varianten
|
EP1594530A4
(de)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
EP1460425A1
(de)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Entglykosilierte Enzymen für Konjugaten
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US20040248323A1
(en)
|
2003-06-09 |
2004-12-09 |
Protometrix, Inc. |
Methods for conducting assays for enzyme activity on protein microarrays
|
AU2004203649B2
(en)
|
2003-08-12 |
2006-01-12 |
F. Hoffmann-La Roche Ag |
Thermostable Taq polymerase fragment
|
PT1704234E
(pt)
|
2003-11-21 |
2012-04-26 |
Nycomed Gmbh |
Produção do péptido tipo glucagon 2 e de análogos do mesmo
|
DE602004025192D1
(de)
*
|
2003-12-05 |
2010-03-11 |
Roche Diagnostics Gmbh |
Rekombinante Carboxypeptidase B und ihre Aufreinigung
|
GB0329722D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
MX2007004662A
(es)
*
|
2004-10-18 |
2007-11-23 |
Globeimmune Inc |
Terapia basada en levaduras para infeccion cronica por hepatitis c.
|
EP1831375B1
(de)
|
2004-12-23 |
2014-07-16 |
Novozymes Biopharma DK A/S |
Genexpressionsmethode
|
JP4690787B2
(ja)
*
|
2005-06-14 |
2011-06-01 |
株式会社日立製作所 |
微生物検知チップ及び微生物検知システム並びに微生物検知方法
|
CA2613257A1
(en)
|
2005-06-24 |
2006-12-28 |
Teijin Pharma Limited |
A novel biological substance nesfatin and its related substances and uses thereof
|
AU2006268333B2
(en)
*
|
2005-07-11 |
2012-06-14 |
Globeimmune, Inc. |
Compositions and methods for eliciting an immune response to escape mutants of targeted therapies
|
US7981635B2
(en)
*
|
2005-09-14 |
2011-07-19 |
Sanofi-Aventis Deutschland Gmbh |
Cleavage of precursors of insulins by a variant of trypsin
|
CA2623197A1
(en)
*
|
2005-09-22 |
2007-03-29 |
Prosci Incorporated |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
US20070172503A1
(en)
|
2005-12-13 |
2007-07-26 |
Mycologics,Inc. |
Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
|
BRPI0709340A2
(pt)
*
|
2006-03-27 |
2013-04-16 |
Globeimmune Inc |
mutaÇço ras e composiÇÕes e mÉtodos de uso da mesma
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
CA2676783C
(en)
*
|
2007-02-02 |
2016-04-05 |
Globeimmune, Inc. |
Improved methods for producing yeast-based vaccines
|
JP2010517577A
(ja)
*
|
2007-02-09 |
2010-05-27 |
メディミューン,エルエルシー |
酵母細胞原形質膜による抗体ライブラリー提示
|
JP5579451B2
(ja)
*
|
2007-03-19 |
2014-08-27 |
グローブイミューン,インコーポレイテッド |
ガンのための標的化治療の変異性回避の標的化アブレーションのための組成物
|
EP2594583A1
(de)
|
2007-08-08 |
2013-05-22 |
Novozymes Biopharma DK A/S |
Transferrinvarianten und Konjugate
|
EP2331125A4
(de)
|
2008-09-19 |
2013-03-27 |
Globeimmune Inc |
Immuntherapie zur für chronische hepatitis-c-virus-infektionen
|
CN102369213A
(zh)
|
2009-02-06 |
2012-03-07 |
诺维信生物制药丹麦公司 |
纯化方法
|
JP5936112B2
(ja)
|
2009-02-11 |
2016-06-15 |
アルブミディクス アクティーゼルスカブ |
アルブミン変異体及び複合体
|
AU2010236206B2
(en)
|
2009-04-17 |
2016-10-20 |
Globeimmune, Inc. |
Combination immunotherapy compositions against cancer and methods
|
AU2010291985B2
(en)
|
2009-09-14 |
2016-05-05 |
The Regents Of The University Of Colorado |
Modulation of yeast-based immunotherapy products and responses
|
BR112012022939A2
(pt)
|
2010-03-11 |
2016-08-02 |
Immune Design Corp |
composição farmacêutica para uso em um método de imunização de um indivíduo em necessidade do mesmo contra um vírus influenza
|
EP2380905A1
(de)
|
2010-04-19 |
2011-10-26 |
Thrombotargets Europe, S.L. |
Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon
|
EP2651439B1
(de)
|
2010-12-17 |
2018-09-19 |
Globeimmune, Inc. |
Zusammensetzungen und verfahren zur behandlung oder vorbeugung von menschlicher adenovirus-36-infektion
|
US8877205B2
(en)
|
2011-02-12 |
2014-11-04 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis B infection
|
KR102046449B1
(ko)
|
2011-03-17 |
2019-11-19 |
글로브이뮨 |
효모-브라큐리 면역요법 조성물
|
CN103732250A
(zh)
|
2011-06-14 |
2014-04-16 |
全球免疫股份有限公司 |
基于酵母的治疗或预防丁型肝炎病毒感染的组合物和方法
|
CA2844500C
(en)
|
2011-08-17 |
2022-05-10 |
Globeimmune, Inc. |
Yeast-muc1 immunotherapeutic compositions and uses thereof
|
EP2864792A1
(de)
|
2012-06-26 |
2015-04-29 |
Biodesix, Inc. |
Massenspektrumsverfahren zur auswahl und zum ausschluss von krebspatienten für eine behandlung mit immunantworterzeugenden therapien
|
US10507235B2
(en)
|
2013-03-19 |
2019-12-17 |
Globeimmune, Inc. |
Yeast-based immunotherapy for Chordoma
|
TWI728239B
(zh)
|
2013-03-26 |
2021-05-21 |
美商環球免疫公司 |
治療或預防人類免疫缺乏病毒感染之組合物及方法
|
TWI654200B
(zh)
|
2013-08-30 |
2019-03-21 |
環球免疫公司 |
治療或預防結核病的組合物及方法
|
US10799567B2
(en)
|
2014-04-11 |
2020-10-13 |
Globeimmune, Inc. |
Yeast-based immunotherapy and type I interferon sensitivity
|
BR112016029076B1
(pt)
|
2014-06-12 |
2024-02-15 |
Ra Pharmaceuticals, Inc |
Polipeptídeo e composição compreendendo o mesmo para inibir a clivagem de c5 em um sistema celular
|
SI3250230T1
(sl)
|
2015-01-28 |
2022-01-31 |
Ra Pharmaceuticals, Inc. |
Modulatorji aktivnosti komplementa
|
EP3331552B1
(de)
|
2015-08-03 |
2021-01-27 |
Globeimmune, Inc. |
Immuntherapeutische zusammensetzungen, die verändertes hefe-brachyury enthalten
|
AU2016370210A1
(en)
|
2015-12-16 |
2018-06-21 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
CN110087668A
(zh)
|
2016-12-07 |
2019-08-02 |
Ra制药公司 |
补体活性的调节剂
|
US10837031B2
(en)
|
2017-05-10 |
2020-11-17 |
Baymedica, Inc. |
Recombinant production systems for prenylated polyketides of the cannabinoid family
|
EP3934752A1
(de)
|
2019-03-08 |
2022-01-12 |
Mevion Medical Systems, Inc. |
Abgabe von strahlung durch eine säule und erzeugung eines behandlungsplanes dafür
|